Publication | Open Access
Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer
100
Citations
37
References
2015
Year
PGK1 is a prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1